Middle East tenders
This article was originally published in Clinica
* Turkey Supply of the following equipment for the Capa and Cerrahpasa medical faculties at Istanbul Technical University: 1) two high-energy and two low-energy linear accelerators with accessories; 2) two automatic isodose printers; 3) two water phantoms; 4) two TLD dosimeter systems; 5) two cobalt-60 treatment units with accessories; 6) phantom and dosimeter systems; 7) two HDR afterloading systems with accessories; 8) two X-ray units with C arms with accessories; 9) two film baths; 10) two treatment simulators with accessories; 11) four film developers; 12) a 3D computerised treatment planning system; 13) a 500-mA radiography and fluoroscope unit; 14) cobalt-60 source for an Alcyon 2 treatment unit; 15) a haemoglobin electrophoresis unit; 16) and one each of the following: intensive care incubator; standard incubator; transport incubator; phototherapy equipment; newborn reanimation unit; mucosa aspirator; neonatal NIBP monitor; pulse oximeter; electric milk pump; laminary flow cabin; apnoea monitor; laryngoscope; syringe pump; cooled centrifuge; microhaematocrit centrifuge; glucometer; microscope; and bilirubinometer.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.